<HashMap><database>iProX</database><scores/><additional><omics_type>Proteomics</omics_type><submitter>Aihua Cao</submitter><species>Homo Sapiens</species><full_dataset_link>http://www.iprox.org/page/project.html?id=IPX0017175000</full_dataset_link><submitter_email>qlyyebk@163.com</submitter_email><submitter_affiliation>Qilu Hospital of Shandong University, Jinan, China</submitter_affiliation><sample_protocol></sample_protocol><repository>iProX</repository><data_protocol></data_protocol></additional><is_claimable>false</is_claimable><name>Plasma Proteomic Analysis in Extremely Premature Infants with Brain Injury</name><description>Brain injury in extremely premature infants (gestational age &lt;32 weeks) causes lifelong neurological sequelae, but the differentially expressed plasma proteins  remains unclear. Nineteen extremely premature infants were enrolled, including 10 with brain injury and 9 without brain injury. Plasma proteomic sequencing were performed. Differential proteins were identified using t test analysis, followed by enrichment analyses. univariate logistic regression and LASSO were applied to identify informative clinical variables. Forty-four differential proteins were identified, which were mainly enriched in cytoskeleton-related functions. Four hub characteristic proteins were screened, including phosphoglycerate kinase 2 (PGK2), metallothionein, C-myc promoter-binding protein (MYCPP), and peroxisomal trans-2-enoyl-CoA reductase (PECR).</description><dates><publication>Mon May 18 00:00:00 BST 2026</publication></dates><accession>PXD078467</accession><cross_references><TAXONOMY>9606</TAXONOMY></cross_references></HashMap>